Cargando…
LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase
Limb and CNS expressed 1 like (LIX1L) is over-expressed in several types of tumors. However, the function of LIX1L in glucose metabolism and hepatocellular carcinoma (HCC) progression remains elusive. Here we report that LIX1L is over-expressed in human HCC tissues, which predicts unfavorable progno...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245913/ https://www.ncbi.nlm.nih.gov/pubmed/34221869 http://dx.doi.org/10.1016/j.apsb.2021.02.005 |
_version_ | 1783716211806175232 |
---|---|
author | Zou, Jie Zhu, Xiaoyun Xiang, Dejuan Zhang, Yanqiu Li, Jie Su, Zhigui Kong, Lingyi Zhang, Hao |
author_facet | Zou, Jie Zhu, Xiaoyun Xiang, Dejuan Zhang, Yanqiu Li, Jie Su, Zhigui Kong, Lingyi Zhang, Hao |
author_sort | Zou, Jie |
collection | PubMed |
description | Limb and CNS expressed 1 like (LIX1L) is over-expressed in several types of tumors. However, the function of LIX1L in glucose metabolism and hepatocellular carcinoma (HCC) progression remains elusive. Here we report that LIX1L is over-expressed in human HCC tissues, which predicts unfavorable prognosis. LIX1L deficiency in vivo significantly attenuated liver cancer initiation in mice. Functional studies indicated that LIX1L overexpression elevated proliferation, migratory, invasive capacities of HCC cells in vitro, and promoted liver cancer growth and metastasis in vivo. LIX1L knockdown up-regulated fructose-1,6-bisphosphatase (FBP1) expression to reduce glucose consumption as well as lactate production. Mechanistically, LIX1L increased miR-21-3p expression, which targeted and suppressed FBP1, thereby promoting HCC growth and metastasis. MiR-21-3p inhibitor could abrogate LIX1L induced enhancement of cell migration, invasion, and glucose metabolism. Inhibition of miR-21-3p suppressed tumor growth in an orthotopic tumor model. Our results establish LIX1L as a critical driver of hepatocarcinogenesis and HCC progression, with implications for prognosis and treatment. |
format | Online Article Text |
id | pubmed-8245913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-82459132021-07-02 LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase Zou, Jie Zhu, Xiaoyun Xiang, Dejuan Zhang, Yanqiu Li, Jie Su, Zhigui Kong, Lingyi Zhang, Hao Acta Pharm Sin B Original Article Limb and CNS expressed 1 like (LIX1L) is over-expressed in several types of tumors. However, the function of LIX1L in glucose metabolism and hepatocellular carcinoma (HCC) progression remains elusive. Here we report that LIX1L is over-expressed in human HCC tissues, which predicts unfavorable prognosis. LIX1L deficiency in vivo significantly attenuated liver cancer initiation in mice. Functional studies indicated that LIX1L overexpression elevated proliferation, migratory, invasive capacities of HCC cells in vitro, and promoted liver cancer growth and metastasis in vivo. LIX1L knockdown up-regulated fructose-1,6-bisphosphatase (FBP1) expression to reduce glucose consumption as well as lactate production. Mechanistically, LIX1L increased miR-21-3p expression, which targeted and suppressed FBP1, thereby promoting HCC growth and metastasis. MiR-21-3p inhibitor could abrogate LIX1L induced enhancement of cell migration, invasion, and glucose metabolism. Inhibition of miR-21-3p suppressed tumor growth in an orthotopic tumor model. Our results establish LIX1L as a critical driver of hepatocarcinogenesis and HCC progression, with implications for prognosis and treatment. Elsevier 2021-06 2021-02-10 /pmc/articles/PMC8245913/ /pubmed/34221869 http://dx.doi.org/10.1016/j.apsb.2021.02.005 Text en © 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Zou, Jie Zhu, Xiaoyun Xiang, Dejuan Zhang, Yanqiu Li, Jie Su, Zhigui Kong, Lingyi Zhang, Hao LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase |
title | LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase |
title_full | LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase |
title_fullStr | LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase |
title_full_unstemmed | LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase |
title_short | LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase |
title_sort | lix1-like protein promotes liver cancer progression via mir-21-3p-mediated inhibition of fructose-1,6-bisphosphatase |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245913/ https://www.ncbi.nlm.nih.gov/pubmed/34221869 http://dx.doi.org/10.1016/j.apsb.2021.02.005 |
work_keys_str_mv | AT zoujie lix1likeproteinpromoteslivercancerprogressionviamir213pmediatedinhibitionoffructose16bisphosphatase AT zhuxiaoyun lix1likeproteinpromoteslivercancerprogressionviamir213pmediatedinhibitionoffructose16bisphosphatase AT xiangdejuan lix1likeproteinpromoteslivercancerprogressionviamir213pmediatedinhibitionoffructose16bisphosphatase AT zhangyanqiu lix1likeproteinpromoteslivercancerprogressionviamir213pmediatedinhibitionoffructose16bisphosphatase AT lijie lix1likeproteinpromoteslivercancerprogressionviamir213pmediatedinhibitionoffructose16bisphosphatase AT suzhigui lix1likeproteinpromoteslivercancerprogressionviamir213pmediatedinhibitionoffructose16bisphosphatase AT konglingyi lix1likeproteinpromoteslivercancerprogressionviamir213pmediatedinhibitionoffructose16bisphosphatase AT zhanghao lix1likeproteinpromoteslivercancerprogressionviamir213pmediatedinhibitionoffructose16bisphosphatase |